| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/05/2008 | US7407947 liposomes containing a sterol skeleton based compound wherein one or several amphoteric groups with an isoelectric point of between 4 and 9 are substituted on the 3rd position of the ring system |
| 08/05/2008 | US7407946 Quinazoline compounds |
| 08/05/2008 | US7407945 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 08/05/2008 | US7407944 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 08/05/2008 | US7407943 Comprises oligonucleotide which targets apolipoprotein nucleotide sequences and prevents expression; gene expresion inhibition; diagnosis and treatment of cardiovascular, infectious, hyperlipidemic and atherosclerotic disorders |
| 08/05/2008 | US7407942 3,6-bridged 9,12-oxolides |
| 08/05/2008 | US7407941 N-desmethyl-N-substituted-11-deoxyerythromycin compounds |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407938 1,4-Diphenyl-3-(3-hydroxy-3-phenylpropyl)-2-azetidinones, e.g., 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-y]lbenzylcarbamoyl}phenoxy)benzoic acid; antilipemic agents that have intestinal absorption of less than 10%, |
| 08/05/2008 | US7407931 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease |
| 08/05/2008 | US7407927 Masking agent for agrichemicals |
| 08/05/2008 | US7407792 Compositions, organisms and methodologies employing a novel human kinase |
| 08/05/2008 | US7407779 Modification of solid 3-sn-phosphoglycerides |
| 08/05/2008 | US7407778 Compounds, compositions and methods for treating neuropsychiatric disorders |
| 08/05/2008 | US7407772 Screening and selection methods for statin drug combinations |
| 08/05/2008 | US7407676 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 08/05/2008 | US7407675 Anti-neoplastic compositions comprising extracts of black cohosh |
| 08/05/2008 | US7407672 Serum and a gelling agent such as gelatin, may further comprise an anticoagulant such as heparin |
| 08/05/2008 | US7407670 Drug having a solubility of less than 1 gram per liter in an aqueous environment dispersed in a vinyl acetate-vinylpyrrolidone copolymer and a second polymer that enhances the dissolution of the drug and is a cationic polymer of 2-(dimethylamino)ethyl methacrylate and a neutral methacrylic ester |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | US7407666 Linear silicone resins in personal care applications |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | US7407659 Methods of diagnosing pre-eclampsia or eclampsia |
| 08/05/2008 | US7407656 PSCA: prostate stem cell antigen and uses thereof |
| 08/05/2008 | US7407648 Protecting human and animal hair or skin from UV radiation by applying a 4,4-disubstituted -1,3-butadienylamine; 4,4-substituents may be the same or different and are cyano, ester, sec. or tert. amide, ketone and/or sulfone, e.g., 4,4-bis(hexyloxycarbonyl)-N,N-diethyl-1,3-butadienylamine |
| 08/05/2008 | CA2505968C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 08/05/2008 | CA2473718C Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
| 08/05/2008 | CA2426632C Atorvastatin hemi-calcium form vii |
| 08/05/2008 | CA2425005C Process for preparing powder formulations |
| 08/05/2008 | CA2423820C New indoline derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 08/05/2008 | CA2418054C Inhibitors of .alpha.4 mediated cell adhesion |
| 08/05/2008 | CA2417081C New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 08/05/2008 | CA2404152C Inhibition of cyclooxygenase-2 activity |
| 08/05/2008 | CA2398035C Timed pulsatile drug delivery systems |
| 08/05/2008 | CA2392903C Trans olefinic glucokinase activators |
| 08/05/2008 | CA2391834C Macrolide antibiotics and treatment of pasteurellosis |
| 08/05/2008 | CA2390787C Combination of riluzole and gabapentin and use thereof as medicine |
| 08/05/2008 | CA2388476C Bicyclic imidazo-5-yl-amine derivatives |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2343575C Inhibition of smooth muscle cell migration by heme oxygenase 1 |
| 08/05/2008 | CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof |
| 08/05/2008 | CA2337586C Alkylation process and novel hydroxyphenylbenztriazoles |
| 08/05/2008 | CA2337098C Anthranilic acid derivatives |
| 08/05/2008 | CA2334577C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/05/2008 | CA2332271C Selective cyclooxygenase-2 anti-inflammatory eye drops |
| 08/05/2008 | CA2331593C Metabolites of ecteinascidin 743 |
| 08/05/2008 | CA2326502C Effervescent formulations |
| 08/05/2008 | CA2319015C Gastroprotected omerprazole microgranules, method for obtaining same and pharmaceutical preparations |
| 08/05/2008 | CA2293549C Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2293358C Tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 08/05/2008 | CA2290622C Selective thyroid hormone analogs |
| 08/05/2008 | CA2290617C Prodrug forms of ribonucleotide reductase inhibitors 3-ap and 3-amp |
| 08/05/2008 | CA2286796C Nucleophile substituted ecteinascidins and n-oxide ecteinascidins |
| 08/05/2008 | CA2286482C Nkt cell-activating agents containing .alpha.-glycosylceramides |
| 08/05/2008 | CA2281706C Methods and compositions for reducing the incidence of necrotizing enterocolitis |
| 08/05/2008 | CA2279319C Benzofurazan compounds which enhance ampa receptor activity |
| 08/05/2008 | CA2273922C Novel saponin compositions and uses thereof |
| 08/05/2008 | CA2268450C Neurotrophin antagonist compositions |
| 08/05/2008 | CA2246715C Antibody variants |
| 08/05/2008 | CA2226457C Oligonucleotides specific for human papilloma virus |
| 08/05/2008 | CA2224435C Pyrrolopyrimidines and processes for the preparation thereof |
| 08/05/2008 | CA2223595C Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 08/05/2008 | CA2223140C Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 08/05/2008 | CA2207136C New 1 or 6-hydroxyl steroids, their preparation process, their application as drugs and the pharmaceutical compositions surrounding them |
| 08/05/2008 | CA2176649C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 08/05/2008 | CA2153984C Process for the manufacture of a tricyclic compound |
| 08/05/2008 | CA2113243C Pharmaceutical compositions containing nanocapsules |
| 08/01/2008 | CA2618154A1 Antithrombotic and anti-restenotic drug eluting stent |
| 07/31/2008 | WO2008092127A1 Use of acetylated or esterificated azacytidine, decitabine, or other nucleoside analogs as oral agents for the treatment of tumors or other dysplastic syndromes sensitive to hypomethylating agents |
| 07/31/2008 | WO2008092103A2 Combination cancer treatments comprising elsamitrucin and other agents |
| 07/31/2008 | WO2008092091A2 Mao inhibiting n-benzyl-n-propargyl-amines useful for treating obesity |
| 07/31/2008 | WO2008092072A2 Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof |
| 07/31/2008 | WO2008092049A1 Anthranilamide inhibitors of aurora kinase |
| 07/31/2008 | WO2008092046A2 Amorphous oxcarbazepine and the production thereof |
| 07/31/2008 | WO2008092006A2 Antimicrobial compositions |
| 07/31/2008 | WO2008091967A1 Chemical compounds |
| 07/31/2008 | WO2008091957A2 Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| 07/31/2008 | WO2008091946A2 N-amino tetrahydrothiazine derivatives, method of manufacture and use |
| 07/31/2008 | WO2008091925A2 Treatment of aortic dissection or aneurysm |
| 07/31/2008 | WO2008091901A1 Heterodimers and methods of using them |
| 07/31/2008 | WO2008091870A2 Pharmaceutical compositions comprising atorvastatin and nicotinic acid |
| 07/31/2008 | WO2008091863A1 Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
| 07/31/2008 | WO2008091860A1 Thiophene derivatives useful as ocular hypotensive agents |
| 07/31/2008 | WO2008091818A1 Substituted arylcyclopentenes as therapeutic agents |
| 07/31/2008 | WO2008091810A1 Substituted arylcylopentenes as therapeutic agents |
| 07/31/2008 | WO2008091770A1 2-aminopyridine derivatives as glucokinase activators |
| 07/31/2008 | WO2008091752A2 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents |
| 07/31/2008 | WO2008091740A2 Polyelectrolyte precipitation and purification of antibodies |
| 07/31/2008 | WO2008091710A2 Methods and compositions for treating neuropathies |
| 07/31/2008 | WO2008091643A2 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 07/31/2008 | WO2008091631A1 Substituted aminopyrimidines as cholecystokinin-1 receptor modulators |
| 07/31/2008 | WO2008091624A2 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 07/31/2008 | WO2008091620A2 Combination therapy comprising romidepsin and i.a. bortezomib |
| 07/31/2008 | WO2008091618A1 Use of d-ribose to treat cardiac arrhythmias |
| 07/31/2008 | WO2008091608A1 Stabilized sulforaphane |
| 07/31/2008 | WO2008091592A1 Intranasal, buccal, and sublingual administration of metanicotine analogs |
| 07/31/2008 | WO2008091588A1 Intranasal, buccal, and sublingual administration of metanicotine analogs |
| 07/31/2008 | WO2008091555A2 Nuclear receptor binding agents |
| 07/31/2008 | WO2008091554A1 Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof |